Isaac Francis

King River Resources (ASX:KRR) announced a pivotal strategic move by entering an agreement to acquire the Mindoolah Gold Project.

Nanoveu (ASX:NVU) announced a landmark exclusive evaluation license agreement with Nanyang Technological University, Singapore.

Adavale Resources (ASX:ADD) announced a strategic expansion of its Parkes Gold-Copper Project.

HealthCo Healthcare & Wellness REIT (ASX:HCW) reported a funds from operations of $12.3 million (2.2cpu) and a net tangible asset value of $1.39 per unit for H1 FY26.

Rhythm Biosciences (ASX:RHY) entered into a strategic distribution service agreement with 4Cyte Pathology, one of Australia's largest independent pathology providers.

Teva Pharmaceutical Industries (NYSE:TEVA) and Sanofi (NASDAQ:SNY) announced a major clinical victory on Tuesday, revealing that their investigational antibody, duvakitug (formerly TEV-574), successfully maintained disease control in patients with inflammatory bowel disease (IBD) for nearly a full year.

Fluor (NYSE:FLR) reported a volatile set of full-year 2025 results on Tuesday, as the engineering and construction giant navigated a major legal setback and a dramatic restructuring of its balance sheet.

Pfizer (NYSE:PFE) today reported positive topline results from Cohort 3 of its pivotal Phase 3 BREAKWATER trial, marking a significant milestone in the treatment of one of the most aggressive forms of colorectal cancer.

Watsco (NYSE:WSO) posted full-year 2025 revenues of $7.24 billion, down 5% from the prior year, reflecting headwinds in equipment volumes offset partially by an 11% increase in average domestic selling prices and contributions from parts and supplies.

Shutterstock (NYSE:SSTK) reported full-year 2025 revenue of $989.9 million, up 6% from $935.3 million in 2024, marking a record high for the creative platform provider.